Development of Formulation Methods and Physical Characterization of Injectable Sodium Selenite Nanoparticles for the Delivery of Sorafenib tosylate

Background: Sorafenib is the first oral therapeutic agent to show the activity against human hepatocellular carcinoma. Sorafenib leads to severe toxicity due to the multiple-dose regimen. Reducing the overall dose of sorafenib through injectable dosage form to release sustainably is of therapeutical...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Pharm Biotechnol
Hlavní autoři: Moni, Sivakumar S., Alam, Mohammad F., Safhi, Mohammed M., Sultan, Muhammad H., Makeen, Hafiz A., Elmobark, Mohamed E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Bentham Science Publishers 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509770/
https://ncbi.nlm.nih.gov/pubmed/31886748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389201021666191230124041
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky